AAAAAA
Results:
1-20
|
Results: 20
Authors:
YAN J
SHAO L
WALSH GM
OMURA GA
SALEH M
DUVIC M
LING M
DIASIO RB
Citation: J. Yan et al., INITIAL MULTIPLE-DOSE PHARMACOKINETICS OF ORAL-ADMINISTRATION OF BCX-34, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 97-97
Authors:
AABO K
ADAMS M
ADNITT P
ALBERTS DS
ATHANAZZIOU A
BARLEY V
BELL DR
BIANCHI U
BOLIS G
BRADY MF
BRODOVSKY HS
BRUCKNER H
BUYSE M
CANETTA R
CHYLAK V
COHEN CJ
COLOMBO N
CONTE PF
CROWTHER D
EDMONSON JH
GENNATAS C
GILBEY E
GORE M
GUTHRIE D
KAYE SB
LAING AH
LANDONI F
LEONARD RC
LEWIS C
LIU PY
MANGIONI C
MARSONI S
MEERPOHL H
OMURA GA
PARMAR MKB
PATER J
PECORELLI S
PRESTI M
SAUERBREI W
SKARLOS DV
SMALLEY RV
SOLOMON HJ
STEWART LA
STURGEON JFG
TATTERSALL MHN
WHARTON JT
HUININK WWT
TOMIROTTI M
TORRI W
TROPE C
TURBOW MM
VERMORKEN JB
WEBB MJ
WILBUR DW
WILLIAMS CJ
WILTSHAW E
YEAP BY
Citation: K. Aabo et al., CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS, British Journal of Cancer, 78(11), 1998, pp. 1479-1487
Authors:
OMURA GA
BLESSING JA
VACCARELLO L
BERMAN ML
CLARKEPEARSON DL
MUTCH DG
ANDERSON B
Citation: Ga. Omura et al., RANDOMIZED TRIAL OF CISPLATIN VERSUS CISPLATIN PLUS MITOLACTOL VERSUSCISPLATIN PLUS IFOSFAMIDE IN ADVANCED SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 15(1), 1997, pp. 165-171
Authors:
TIERNEY JF
STEWART LA
PARMAR MKB
FLETCHER CDM
JONES G
MOSSERI V
PATEL M
DEELVIRA MCR
SOUHAMI RL
SYLVESTER R
TURSZ T
ALVEGARD TA
SIGURDSSON H
ANTMAN K
BACCHI M
BAKER LH
BENJAMIN RS
BRADY MF
BRAMWELL V
BUI BN
EDMONSON JH
LEYVRAZ S
OMURA GA
ROUESSE J
RYAN L
VANOOSTEROM AT
YANG JC
Citation: Jf. Tierney et al., ADJUVANT CHEMOTHERAPY FOR LOCALIZED RESECTABLE SOFT-TISSUE SARCOMA OFADULTS - METAANALYSIS OF INDIVIDUAL DATA, Lancet, 350(9092), 1997, pp. 1647-1654
Authors:
HARMAN GS
OMURA GA
RYAN K
HAINSWORTH JD
CRAMER MB
HAHNE WF
Citation: Gs. Harman et al., A RANDOMIZED, DOUBLE-BLIND COMPARISON OF SINGLE-DOSE AND DIVIDED MULTIPLE-DOSE DOLASETRON FOR CISPLATIN-INDUCED EMESIS, Cancer chemotherapy and pharmacology, 38(4), 1996, pp. 323-328
Authors:
SAMS WM
OMURA EF
BARTOLUCCI AA
COOK WJ
OMURA GA
Citation: Wm. Sams et al., DOUBLE-BLIND, PAIRED-COMPARISON OF BCX-34 VERSUS PLACEBO IN THE TREATMENT OF PSORIASIS-VULGARIS, Journal of investigative dermatology, 106(4), 1996, pp. 836-836
Authors:
SALEH MN
DIASIO RB
SAMS WM
WHEELER RH
GREGG X
OMURA GA
WALSH GM
Citation: Mn. Saleh et al., PHASE-I EVALUATION OF ORAL BCX-34 (PELDESINE) IN CUTANEOUS T-CELL LYMPHOMA (CTCL), Blood, 88(10), 1996, pp. 2277-2277
Authors:
VOGLER WR
WEINER RS
MOORE JO
OMURA GA
BARTOLUCCI AA
STAGG M
Citation: Wr. Vogler et al., LONG-TERM FOLLOW-UP OF A RANDOMIZED POSTINDUCTION THERAPY TRIAL IN ACUTE MYELOGENOUS LEUKEMIA - (A SOUTHEASTERN CANCER STUDY-GROUP TRIAL), Leukemia, 9(9), 1995, pp. 1456-1460
Authors:
BARNHILL DR
KURMAN RJ
BRADY MF
OMURA GA
YORDAN E
GIVEN FT
KUCERA PR
ROMAN LD
Citation: Dr. Barnhill et al., PRELIMINARY-ANALYSIS OF THE BEHAVIOR OF STAGE-I OVARIAN SEROUS TUMORSOF LOW MALIGNANT POTENTIAL - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 13(11), 1995, pp. 2752-2756
Authors:
FLEMING RA
CAPIZZI RL
ROSNER GL
OLIVER LK
SMITH SJ
SCHIFFER CA
SILVER RT
PETERSON BA
WEISS RB
OMURA GA
MAYER RJ
VANECHO DA
BLOOMFIELD CD
SCHILSKY RL
Citation: Ra. Fleming et al., CLINICAL-PHARMACOLOGY OF CYTARABINE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA - A CANCER AND LEUKEMIA GROUP-B STUDY, Cancer chemotherapy and pharmacology, 36(5), 1995, pp. 425-430
Authors:
OMURA GA
SILLER BS
Citation: Ga. Omura et Bs. Siller, PRIMARY CHEMOTHERAPY OF EPITHELIAL OVARIAN-CARCINOMA, Seminars in surgical oncology, 10(4), 1994, pp. 283-289
Authors:
OMURA GA
VOGLER WR
MARTELO O
GORDON DS
BARTOLUCCI AA
Citation: Ga. Omura et al., LATE INTENSIFICATION THERAPY IN ADULT ACUTE LYMPHOID LEUKEMIA - LONG-TERM FOLLOW-UP OF THE SOUTHEASTERN-CANCER-STUDY-GROUP EXPERIENCE, Leukemia & lymphoma, 15(1-2), 1994, pp. 71-78
Authors:
VOGLER WR
MCCARLEY DL
STAGG M
BARTOLUCCI AA
MOORE J
MARTELO O
OMURA GA
Citation: Wr. Vogler et al., A PHASE-III TRIAL OF HIGH-DOSE CYTOSINE-ARABINOSIDE WITH OR WITHOUT ETOPOSIDE IN RELAPSED AND REFRACTORY ACUTE MYELOGENOUS LEUKEMIA - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL, Leukemia, 8(11), 1994, pp. 1847-1853
Authors:
OMURA GA
PERRI RT
PETERSON B
SCHIFFER CA
Citation: Ga. Omura et al., CARBOPLATIN IN PREVIOUSLY TREATED MULTIPLE-MYELOMA - A CANCER AND LEUKEMIA GROUP-B PHASE-II TRIAL, American journal of clinical oncology, 17(3), 1994, pp. 196-198
Authors:
OMURA GA
BASS D
Citation: Ga. Omura et D. Bass, PROGNOSTIC FACTOR-ANALYSIS OF CENTRAL-NERVOUS-SYSTEM RELAPSE IN ADULTACUTE LYMPHOBLASTIC-LEUKEMIA - A SOUTHEASTERN CANCER STUDY-GROUP REPORT, American journal of clinical oncology, 17(2), 1994, pp. 93-96
Authors:
OMURA GA
Citation: Ga. Omura, CHEMOTHERAPY FOR CERVIX CANCER, Seminars in oncology, 21(1), 1994, pp. 54-62
Authors:
MAYER RJ
DAVIS RB
SCHIFFER CA
BERG DT
POWELL BL
SCHULMAN P
OMURA GA
MOORE JO
MCINTYRE OR
FREI E
Citation: Rj. Mayer et al., INTENSIVE POSTREMISSION CHEMOTHERAPY IN ADULTS WITH ACUTE MYELOID-LEUKEMIA, The New England journal of medicine, 331(14), 1994, pp. 896-903
Authors:
PARKER BA
PETRONI GR
CANELLOS GP
GOCKERMAN JP
COOPER MR
OMURA GA
JOHNSON JL
PETERSON BA
Citation: Ba. Parker et al., DOSE-INTENSIFIED CYCLOPHOSPHAMIDE (C) AND ETOPOSIDE (E) IN CHOP-PLUS-E (CHOPE) THERAPY OF DIFFUSE LYMPHOMAS (IWF E-H), CALGB-8852, Blood, 84(10), 1994, pp. 10000384-10000384
Authors:
OMURA GA
Citation: Ga. Omura, ONCOLOGY (THE STUDY OF CANCER) IS MORE THAN CHEMOTHERAPY, Journal of clinical oncology, 11(9), 1993, pp. 1837-1837
Authors:
JOHNSON DH
BASS D
EINHORN LH
CRAWFORD J
PEREZ CA
BARTOLUCCI A
OMURA GA
GRECO FA
Citation: Dh. Johnson et al., COMBINATION CHEMOTHERAPY WITH OR WITHOUT THORACIC RADIOTHERAPY IN LIMITED-STAGE SMALL-CELL LUNG-CANCER - A RANDOMIZED TRIAL OF THE SOUTHEASTERN CANCER STUDY-GROUP, Journal of clinical oncology, 11(7), 1993, pp. 1223-1229
Risultati:
1-20
|